You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -5.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 3.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -2.3% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | n/a | -1.45 | -4.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -3.21 | -8.40p | -17.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -6.01 | -11.90p | -5.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -5.52 | -10.70p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 0.00 | -5.86 | -10.55p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 0.00 | -3.52 | -5.98p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Destiny Pharma enters collaboration deal with SporeGen Sharecast News | 07 Sep |
|---|---|
| Destiny Pharma reports positive safety review of XF-73 trials Sharecast News | 11 Aug |
| Destiny Pharma awarded grant for Cardiff research collaboration Sharecast News | 09 Jun |
| Interim results for the 6 months ended 30 Jun 2020 | 17-Sep-20 07:04 |
|---|---|
| Update on Phase 2b clinical study of XF-73 | 17-Sep-20 07:04 |
| Notice of Results | 10-Sep-20 07:09 |
| Second Price Monitoring Extn | 07-Sep-20 16:42 |
| Price Monitoring Extension | 07-Sep-20 16:36 |